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Blood pressure and site-specific cancer mortality: evidence from
the original Whitehall study
GD Batty*,1, MJ Shipley2, MG Marmot2 and G Davey Smith3
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Studies relating blood pressure to cancer risk have some shortcomings and have revealed inconsistent findings. In 17 498 middle-aged
London-based government employees we related systolic and diastolic blood pressure recorded at baseline examination (1967–
1970) to the risk of cancer mortality risk at 13 anatomical sites 25 years later. Following adjustment for potential confounding and
mediating factors, inverse associations between blood pressure and mortality due to leukaemia and cancer of the pancreas (diastolic
only) were seen. Blood pressure was also positively related to cancer of the liver and rectum (diastolic only). The statistically
significant blood pressure–cancer associations seen in this large-scale prospective investigation offering high power were scarce and
of sufficiently small magnitude as to be attributable to chance or confounding.
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Examination of the predictive value of blood pressure for
later mortality has a long research pedigree: among the earliest
investigations of risk were those undertaken by the US life
insurance industry over four decades ago (Society of Actuaries,
1959). The finding in this study of a positive relation between
blood pressure and all-cause mortality was later demonstrated
for cardiovascular disease (CVD) (Kannel et al, 1986; Miura
et al, 2001). In these investigations, the magnitude of the relation
of blood pressure with CVD is typically greater than that be-
tween blood pressure and total mortality; similarly, in randomised
trials, anti-hypertensive drug treatment lowers CVD incidence
but not necessarily total mortality (Neal et al, 2000). This
suggests that the association between blood pressure and non-
CVD causes of death – including cancer – is null or possibly even
negative.
The potential link between blood pressure and cancer risk was
first examined by de Waard and Baanders-van Halewijn (1974) in a
cohort of women, and Dyer et al (1975) in a cohort of men, where
the finding of a positive relation prompted a series of subsequent
investigations (Svardsudd and Tibblin, 1979; Raynor et al, 1981;
Khaw and Barrett-Connor, 1984; Goldbourt et al, 1986; Fraser et al,
1990; Grove et al, 1991; Filipovsky et al, 1993; Hole et al, 1993;
Wannamethee and Shaper, 1996). Collectively (Grossman et al,
2002), there is some evidence that blood pressure is related to an
elevated risk of all-cancers combined and renal cancer. Owing to a
general paucity of data, however, the relationship between blood
pressure and other cancer sites is inconclusive and justifies further
examination. Further, existing data are hampered by methodolo-
gical issues, including reverse causality, lack of adjustment for
some potential confounding factors, and inadequate statistical
power owing to a small number of cases.
Against this background of inconsistent findings and study
limitations we examined the relation of blood pressure to cancer
risk at 13 anatomical sites using a 25-year mortality surveillance of
18 403 male government workers in the original Whitehall study, a
prospective investigation.
MATERIALS AND METHODS
In the Whitehall study, data were collected on 18 403 non-
industrial London-based male government employees aged from
40 to 64 years when examined between September 1967 and
January 1970, representing a 74% response proportion. Data
collection involved the completion of a study questionnaire and
participation in a medical examination, both of which have been
described in detail elsewhere (Reid et al, 1974). In brief, the
questionnaire included enquiries regarding civil service employ-
ment grade (our indicator of socioeconomic position) (Marmot
et al, 1978), smoking habits (Reid et al, 1976), intermittent
claudication (Rose, 1962; Davey Smith et al, 1990), angina (Rose,
1962; Rose et al, 1977b), chronic bronchitis (Committee on the
Aetiology of Chronic Bronchitis, 1965) and use of medication,
including blood pressure-lowering drugs. Forced expiratory
volume in 1 s (FEV1) (adjusted for height (Batty et al, 2002)),
ischaemia (Rose et al, 1977a), fasting plasma cholesterol (Davey
Smith et al, 1992), 2-h blood glucose (Jarrett et al, 1986), height
(Leon et al, 1995), and weight (Jarrett et al, 1982) were determined
using standardised protocols.
Assessment of blood pressure
Having been seated while the questionnaire was checked, blood
pressure was recorded from a single reading taken from the left
arm by a trained observer (Rose, 1965) using a calibrated London
School of Hygiene sphygmomanometer (Rose et al, 1964). SystolicReceived 7 May 2003; revised 11 July 2003; accepted 11 July 2003
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blood pressure was recorded at the first appearance of the
Korotkoff sounds; diastolic pressure was recorded at both their
muffling (phase IV) and disappearance (phase V).
Ascertainment of cancer mortality
The records of 18 260 men (99.2% of subjects) were traced and
‘flagged’, using the procedures of the Office for National Statistics
(Southport), until 31 January 1995. Death certificates were coded
according to the eighth revision of the International Classification
of Diseases (ICD) (Anon., 1967). The category of all malignant
neoplasms (ICD 140-208) – referred to here as ‘all-cancers’ – was
divided into 13 individual sites: oesophagus (ICD 150); stomach
(ICD 151); colon (ICD 153); rectum (ICD 154); liver (ICD 155–
156); pancreas (ICD 157); trachea, bronchus and lung (ICD
162 – referred to as ‘lung cancer’); prostate (ICD 185); bladder
(ICD 188); kidney (ICD 189); brain (ICD 191); lymphoma (ICD
200– 203); and leukaemia (ICD 204–207).
Data analyses
Our analyses are based on 17 498 men without missing data and
exclude 26 men for whom the cause of death was unknown. In
analyses of baseline characteristics according to levels of blood
pressure, the prevalence of these characteristics were adjusted for
age (5-year age groups) by the direct standardisation method.
Trends in these proportions were tested for statistical significance
using the Mantel–Haenszel test. For baseline characteristics
expressed as continuous variables, least-squares means were used
to present the age-adjusted means, and tests for trend across blood
pressure groups were computed by fitting a linear trend term.
Cox’s (Cox, 1972) proportional hazards regression model was
used to compute rate ratios and accompanying confidence
intervals for the association between components of blood
pressure and each mortality outcome. In these analyses we divided
each component of blood pressure into tertiles, using the lowest
tertile as the referent category. We also fitted systolic and diastolic
blood pressure as continuous variables, using these coefficients to
test for linear trend and compute the rate ratio per 10 mmHg
increase in each blood pressure component.
These models were initially adjusted for age and then for other
potential confounding (employment grade, smoking status, blood
pressure-lowering medication, marital status, disease at study
entry) and mediating (body mass index, triceps skinfold thickness,
FEV1, cholesterol) variables. Age, cholesterol, body mass index,
triceps skinfold thickness, and height-adjusted FEV1 were fitted as
continuous variables, whereas employment grade (five levels),
marital status (four), blood pressure-lowering medication (two),
smoking status (four) (with additional adjustment for the number
of cigarettes smoked per day in current smokers) and disease at
entry (two) were fitted as categorical variables. Disease at entry
was defined as a positive response to enquiries regarding one or
more of the following at study entry: unexplained weight loss in the
preceding year, bronchitis, diabetes (based on self-report and
blood glucose levels), ischaemia (based on self-report and ECG
trace), intermittent claudication, dyspnoea, or care of a general
practitioner for raised blood pressure or heart problems.
For some malignancies (e.g., renal cancer), tumour presence
may elevate blood pressure so generating a positive blood
pressure–cancer association. To address this issue of reverse
causality, we excluded deaths in the first 10 years of follow-up and
repeated our analyses. In doing so, we reasoned that a large
proportion of deaths attributable to cancer, if present at study
induction, would have occurred within this time frame (Brenner,
2002).
RESULTS
The relation of components of blood pressure to baseline physical
characteristics is presented in Table 1. Cigarette smoking was
inversely related to blood pressure levels, such that the lowest
prevalence was seen in the higher tertiles of each blood pressure
component. For all other characteristics, however, the most
favourable levels of each was apparent in the lower blood pressure
groups with statistical significance seen for most, if not all
relationships.
In this cohort there were 7460 deaths over 25 years of follow-up.
A total of 2226 deaths were ascribed to all-cancers, the most
common site being that of the lung (30% of cancer deaths). Rate
ratios for the association of systolic and diastolic blood pressure
with mortality from all cancers and site-specific cancers are
depicted in Tables 2 and 3. Given that the results of models
adjusting for confounding variables only, and confounding and
mediating variables combined, were very similar, we only present
the latter as ‘multiple’ adjustment.
Both systolic and diastolic blood pressure were essentially
unrelated to total cancer mortality. In age-adjusted analyses,
inverse associations of cancer of the lung, and pancreas, and
leukaemia with blood pressure were seen at conventional levels of
statistical significance. Following multiple adjustment, the relation-
Table 1 Association between components of blood pressure and baseline physical characteristicsa
Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg)
Tertile 1 Tertile 2 Tertile 3 Tertile 1 Tertile 2 Tertile 3
(p125) (126–142) (X143) P-trend (p77) (78–88) (X89) P-trend
Number 5833 5947 5718 — 5573 6096 5829 —
Mean (s.e.)
Age 50.2 (0.08) 51.2 (0.08) 53.3 (0.08) o0.001 51.0 (0.08) 51.3 (0.08) 52.3 (0.08) o0.001
Tricep skinfold thickness (mm) 42.3 (0.21) 44.9 (0.21) 47.0 (0.21) o0.001 41.4 (0.21) 44.6 (0.20) 48.0 (0.21) o0.001
Body mass index (kg m2) 24.0 (0.04) 24.8 (0.04) 25.5 (0.04) o0.001 23.7 (0.04) 24.7 (0.04) 25.8 (0.04) o0.001
Plasma cholesterol (mmol l1) 5.07 (0.02) 5.12 (0.02) 5.14 (0.02) 0.002 5.03 (0.02) 5.13 (0.02) 5.16 (0.02) o0.001
FEV1
b (l s1) 3.15 (0.01) 3.15 (0.01) 3.09 (0.01) o0.001 3.14 (0.01) 3.14 (0.01) 3.11 (0.01) 0.004
Percent (s.e.)
Current cigarette smoker 44.2 (0.67) 41.0 (0.64) 39.0 (0.66) o0.001 47.5 (0.67) 40.7 (0.63) 36.3 (0.63) o0.001
Low work grade 23.1 (0.57) 22.8 (0.53) 25.2 (0.55) 0.007 23.8 (0.56) 22.7 (0.52) 25.0 (0.54) 0.12
No partner 11.7 (0.43) 11.4 (0.41) 12.3 (0.45) 0.31 11.6 (0.43) 11.5 (0.41) 12.5 (0.44) 0.18
Disease at study entry 21.0 (0.55) 21.2 (0.53) 26.7 (0.59) o0.001 21.1 (0.55) 21.4 (0.52) 26.3 (0.57) o0.001
Blood pressure-lowering medication 0.08 (0.03) 0.59 (0.10) 3.72 (0.25) o0.001 0.11 (0.04) 0.74 (0.11) 3.59 (0.24) o0.001
aAdjusted for age (age is unadjusted). bFEV1¼ forced expiratory volume in 1 s adjusted for height.
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Table 2 Rate ratios (95% confidence intervals) for systolic and diastolic blood pressure in relation to site-specific cancer mortality
All-cancers Lung Oesophagus Stomach Pancreas Colon Rectum
(2226 deaths) (658 deaths) (77 deaths) (157 deaths) (107 deaths) (198 deaths) (71 deaths)
Age-
adjusted
Multiply-
adjusteda
Age-
adjusted
Multiply-
adjusted
Age-
adjusted
Multiply-
adjusted
Age-
adjusted
Multiply-
adjusted
Age-
adjusted
Multiply-
adjusted
Age-
adjusted
Multiply-
adjusted
Age-
adjusted
Multiply-
adjusted
Systolic blood pressure (mmHg)
Tertile 3 0.96 0.98 0.76 0.82 1.23 1.14 1.21 1.18 0.73 0.72 0.81 0.78 1.27 1.20
(X143) (0.87, 1.07) (0.89, 1.10) (0.62, 0.92) (0.67, 1.00) (0.70, 2.13) (0.64, 2.01) (0.82, 1.77) (0.80, 1.76) (0.45, 1.18) (0.44, 1.19) (0.57, 1.14) (0.55, 1.12) (0.71, 2.27) (0.66, 2.17)
Tertile 2 0.94 0.97 0.86 0.94 1.00 0.98 0.90 0.91 0.86 0.87 0.80 0.80 1.03 1.00
(126 – 142) (0.85, 1.05) (0.88, 1.07) (0.72, 1.04) (0.78, 1.13) (0.57, 1.75) (0.56, 1.72) (0.60, 1.35) (0.61, 1.37) (0.55, 1.35) (0.55, 1.36) (0.57, 1.12) (0.57, 1.12) (0.57, 1.87) (0.55, 1.81)
Tertile 1 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
(p125)
Per 10 mmHg 1.00 1.00 0.95 0.97 1.00 0.98 1.06 1.05 0.94 0.94 0.96 0.95 1.04 1.03
increase (0.97, 1.02) (0.98, 1.02) (0.92, 0.99) (0.93, 1.01) (0.90, 1.12) (0.88, 1.11) (0.98, 1.14) (0.98, 1.14) (0.85, 1.04) (0.85, 1.04) (0.89, 1.03) (0.88, 1.02) (0.93, 1.16) (0.91, 1.16)
P for trend 0.62 0.89 0.011 0.15 0.94 0.79 0.15 0.18 0.21 0.22 0.24 0.17 0.54 0.65
Diastolic blood pressure (mmHg)
Tertile 3 0.91 0.99 0.63 0.79 1.30 1.24 1.11 1.14 0.63 0.64 0.98 0.94 1.88 1.84
(X89) (0.82, 1.01) (0.89, 1.10) (0.52, 0.76) (0.65, 0.97) (0.71, 2.38) (0.66, 2.32) (0.76, 1.62) (0.76, 1.70) (0.39, 1.02) (0.39, 1.05) (0.70, 1.38) (0.65, 1.34) (1.06, 3.34) (1.01, 3.34)
Tertile 2 0.86 0.92 0.72 0.85 1.64 1.66 0.90 0.94 0.72 0.74 0.88 0.86 0.96 0.95
(78 – 88) (0.78, 0.96) (0.83, 1.02) (0.60, 0.86) (0.71, 1.02) (0.94, 2.88) (0.94, 2.93) (0.61, 1.34) (0.64, 1.40) (0.46, 1.13) (0.47, 1.17) (0.63, 1.24) (0.61, 1.22) (0.50, 1.83) (0.50, 1.82)
Tertile 1 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
(p77)
Per 10 mmHg 0.99 1.02 0.90 0.98 1.01 0.99 1.03 1.04 0.86 0.86 0.96 0.95 1.19 1.19
increase (0.96, 1.02) (0.99, 1.06) (0.85, 0.95) (0.92, 1.04) (0.85, 1.20) (0.83, 1.18) (0.92, 1.16) (0.92, 1.18) (0.74, 1.00) (0.73, 1.01) (0.87, 1.07) (0.85, 1.06) (1.01, 1.40) (1.00, 1.41)
P for trend 0.50 0.24 0.0004 0.46 0.88 0.89 0.61 0.52 0.05 0.06 0.51 0.36 0.04 0.05
aAdjustment for confounding (age, employment grade, smoking status, blood pressure-lowering medication, marital status, disease at study entry) and mediating (body mass index, triceps skinfold thickness, FEV1, cholesterol) variables.
Table 3 Rate ratios (95% confidence intervals) for systolic and diastolic blood pressure in relation to site-specific cancer mortalitya
Prostate Bladder Brain Leukaemia Lymphoma Liver Kidney
(252 deaths) (92 deaths) (47 deaths) (76 deaths) (107 deaths) (38 deaths) (47 deaths)
Age-
adjusted
Multiply-
adjusteda
Age-
adjusted
Multiply-
adjusted
Age-
adjusted
Multiply-
adjusted
Age-
adjusted
Multiply-
adjusted
Age-
adjusted
Multiply-
adjusted
Age-
adjusted
Multiply-
adjusted
Age-
adjusted
Multiply-
adjusted
Systolic blood pressure (mmHg)
Tertile 3 0.96 1.05 1.07 1.18 1.10 1.07 0.69 0.66 1.07 1.03 6.12 5.35 1.42 1.26
(X143) (0.71,1.31) (0.76,1.44) (0.62, 1.85) (0.67, 2.06) (0.55, 2.18) (0.53, 2.15) (0.40, 1.19) (0.38, 1.17) (0.66, 1.76) (0.62, 1.72) (2.07, 18.1) (1.78, 16.1) (0.72, 2.82) (0.62, 2.59)
Tertile 2 0.97 0.99 1.44 1.53 0.75 0.73 0.61 0.60 1.25 1.24 3.55 3.54 0.77 0.78
(126 – 142) (0.72,1.32) (0.73,1.35) (0.87, 2.39) (0.92, 2.54) (0.37, 1.55) (0.35, 1.51) (0.35, 1.06) (0.35, 1.04) (0.79, 1.97) (0.78, 1.96) (1.17, 10.8) (1.16, 10.8) (0.36, 1.66) (0.36, 1.67)
Tertile 1 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
(p125)
Per 10 mmHg 1.00 1.02 1.04 1.06 0.99 0.99 0.91 0.90 1.03 1.02 1.23 1.19 1.10 1.06
increase (0.93,1.06) (0.95,1.08) (0.94, 1.14) (0.96, 1.18) (0.86, 1.15) (0.85, 1.16) (0.80, 1.02) (0.79, 1.01) (0.93, 1.13) (0.92, 1.12) (1.07, 1.41) (1.03, 1.37) (0.96, 1.25) (0.92, 1.21)
P for trend 0.93 0.61 0.48 0.25 0.94 0.92 0.10 0.08 0.61 0.74 0.003 0.02 0.17 0.45
Diastolic blood pressure (mmHg)
Tertile 3 1.05 1.15 0.81 0.95 0.51 0.45 0.57 0.54 1.19 1.20 3.44 3.03 1.21 1.12
(X89) (0.77,1.44) (0.83,1.59) (0.48, 1.36) (0.54, 1.64) (0.23, 1.13) (0.20, 1.04) (0.33, 0.98) (0.30, 0.96) (0.76, 1.87) (0.75, 1.93) (1.26, 9.40) (1.07, 8.59) (0.62, 2.37) (0.54, 2.29)
Tertile 2 1.12 1.15 1.05 1.15 1.02 0.95 0.54 0.53 0.77 0.80 3.17 3.21 0.69 0.70
(78– 88) (0.83,1.51) (0.85,1.56) (0.65, 1.70) (0.71, 1.87) (0.54, 1.93) (0.50, 1.82) (0.32, 0.98) (0.31, 0.92) (0.47, 1.25) (0.49, 1.30) (1.17. 8.59) (1.17, 8.77) (0.33, 1.46) (0.33, 1.48)
Tertile 1 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
(p77)
Per 10 mmHg 1.00 1.03 1.01 1.08 1.00 0.99 0.83 0.81 1.10 1.11 1.42 1.38 1.15 1.09
increase (0.91,1.10) (0.93,1.14) (0.87, 1.18) (0.92, 1.27) (0.81, 1.24) (0.78, 1.25) (0.69, 0.99) (0.67, 0.98) (0.96, 1.27) (0.96, 1.29) (1.16, 1.73) (1.10, 1.73) (0.94, 1.41) (0.88, 1.36)
P for trend 0.99 0.62 0.87 0.36 0.99 0.93 0.04 0.03 0.17 0.17 0.001 0.005 0.19 0.42
aAdjustment for confounding (age, employment grade, smoking status, blood pressure-lowering medication, marital status, disease at study entry) and mediating (body mass index, triceps skinfold thickness, FEV1, cholesterol) variables.
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ship with lung cancer was lost. Blood pressure was positively
related to cancer of the rectum (diastolic only) and liver; confidence
intervals latter, confidence intervals were wide owing to the low
number of deaths. In the analyses in which we excluded deaths
occurring in the first 10 years of follow-up, a positive association
between diastolic, but not systolic, blood pressure and lymphoma
emerged (rate ratio, 95% confidence interval for 10 mmHg increase
in blood pressure; 1.16, 0.99–1.36, P [trend]¼ 0.07).
DISCUSSION
In this large, prospective cohort study, blood pressure was related
to few of the cancer end points under investigation at conventional
levels of statistical significance. Thus, an inverse association
between blood pressure and mortality due to pancreatic cancer
(diastolic only) and leukaemia was seen after adjustment for
potential confounding and mediating factors. After exclusion of
deaths in the first decade of follow-up, the relation for leukaemia
was lost. Both systolic and diastolic blood pressure were positively
related to cancer of the liver, rectum and, after exclusion of early
deaths, lymph nodes.
Confounding and reverse causality
The interpretation of the findings of several studies of the blood
pressure–cancer relation is complicated by issues of confounding
and reverse causality. The effect of potentially important
confounding variables such as social circumstances, alcohol
consumption and anti-hypertensive medications is rarely explored.
Anti-hypertensive medications have been linked to increased risk
of malignancy in some (Armstrong et al, 1974; Fletcher et al, 1993)
but not all (Dyer et al, 1975; Raynor et al, 1981) studies, raising the
possibility that it is not high blood pressure or hypertension per se
that is generating the association. However, few investigators have
data on medication and blood pressure levels to allow them to
explore this issue. In the present study, the already weak blood
pressure–cancer associations seen after controlling for age were
generally little altered when we added other factors to our
regression models. While information on those men taking
medication for high blood pressure was available, the prevalence
at baseline was very low (1.5%), and there were insufficient cancer
deaths in this group to examine either the predictive value of blood
pressure-lowering drugs for cancer risk or explore their potential
confounding effect.
We observed a positive relation between blood pressure and
liver cancer. Many of these malignancies would have been
attributable to alcohol-induced cirrhosis of the liver, a precipitat-
ing condition. Both systolic and diastolic blood pressure were
positively and incrementally related to liver cirrhosis deaths rates
(rate ratio, 95% confidence interval for 10 mmHg increase in
systolic blood pressure; 1.21, 1.04–1.41, P [trend]¼ 0.01). This
suggests that the positive blood pressure –liver cancer relation may
be confounded by alcohol consumption; however, we only have
data on alcohol intake for a 10% subsample of the cohort – too few
to investigate this possibility. We are unaware of any other studies
to have examined the link between blood pressure and liver cancer,
a scarcity that is also apparent for pancreatic cancer and
leukaemia.
In a small study of renal cancer patients, blood pressure levels
normalised following tumour removal (Lee, 1971); while in others
(Kirchner et al, 1976; Melman et al, 1977) the prevalence of renal
cell carcinoma in hypertension patients exceeded that in the
general population. It is therefore plausible that, for this type of
neoplasm, which has been consistently linked with high blood
pressure levels (Grossman et al, 2002), the presence of tumours
may raise blood pressure, rather than the reverse, so generating a
positive blood pressure–cancer association (Buck and Donner,
1987). In the present analyses, risk of mortality from this cancer
was also elevated in the high blood pressure groups, but not
significantly so. The high number of cancer deaths in the present
study afforded us the opportunity of exploring this issue in more
depth. On excluding deaths from renal cancer occurring in the first
10 years of follow-up, this association was eliminated suggesting
that reverse causality may be the underlying explanation. This is
also a likely justification for the blood pressure –leukaemia
association.
In none of our analyses was either component of blood pressure
related to mortality from cancer of combined sites. Findings from
other studies are inconsistent with positive (Svardsudd and
Tibblin, 1979; Goldbourt et al, 1986; Fraser et al, 1990; Filipovsky
et al, 1993) and null (Grove et al, 1991; Hole et al, 1993)
associations reported. Owing to its high incidence, lung cancer is
the site-specific malignancy most commonly examined in relation
to blood pressure. In the present study, there was a weak, inverse
relation of systolic and diastolic blood pressure with lung cancer, a
finding that is, again, supported by some (Khaw and Barrett-
Connor, 1984), but not all (Svardsudd and Tibblin, 1979;
Goldbourt et al, 1986), investigators.
To summarize, of the associations observed, blood pressure and
liver cancer is likely to be due to confounding by alcohol
consumption, while blood pressure and leukaemia is probably
attributable to reverse causality, as described. For the remaining
two statistically significant relationships, rectal and pancreatic
cancer were essentially null for systolic blood pressure and barely
reached statistical significance for diastolic pressure. Given that we
related 17 outcomes (the cancers plus total mortality, CHD, and
stroke) to two components of blood pressure, it is highly plausible
that these latter two associations are attributable to the play of
chance, or, because of their small magnitude, confounding by
unmeasured factors, residual confounding by measured factors, or
both.
Limitations of the present study
In the present study, systolic and diastolic blood pressure were
measured on a single occasion, raising concerns about validity. We
addressed this issue by relating these exposures to coronary heart
disease and stroke mortality, both of which have been shown to be
positively associated with systolic and diastolic blood pressure in a
pooling of individual level data for one million subjects
(Lewington et al, 2002). In the present analyses, as in earlier
follow-ups of the same cohort (Lichtenstein et al, 1985), the
relationship between blood pressure and both these end points was
positive, incremental, and strong, suggesting our blood pressure
data have predictive validity. It is also likely that our blood
pressure measurements would have changed over 25 years of
follow-up. Given that these fluctuations would have been non-
differential with respect to the outcome of interest, any reported
associations would have been weaker than the true, underlying
relationships (Armstrong et al, 1994).
In conclusion, in this large-scale prospective investigation of male
government employees offering a large number of cases, an inverse
association between blood pressure and mortality from cancer of the
pancreas and leukaemia was seen, while blood pressure was
positively related to liver and rectal cancer risk. That these
relationships were few among the many analyses we conducted,
and of small magnitude, suggests that they are likely to be due to
chance and/or confounding rather than being real effects.
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